YKL-40 IN SERA OF BREAST TUMOR PATIENTS

Journal Title: Journal of IMAB - Annual Proceeding (Scientific Papers) - Year 2010, Vol 16, Issue 3

Abstract

YKL-40, also known as human cartilage glycoprotein 39, is a member of the “mammalian chitinase-like proteins”, but lacking of chitinase activity. Increased variations in serum concentrations are associated with inflammatory processes and several types of cancer. In this study we evaluated serum YKL-40 levels in healthy controls and in women with benign and malignant breast tumors. YKL-40 serum levels were measured by enzyme-linked immunosorbent assay – ELISA in 32 patients. The effect of the various factors was analyzed using correlation and regression analyses simultaneously determining the size and direction of correlation. The level of statistical significance of null hypothesis was P<0.05. Our study showed that serum YKL-40 level in breast carcinoma was significantly higher than the concentration in healthy controls (p<0.01). The changes in protein levels were higher than 25%. Serum YKL-40 increased with age (rxy=0.46). The correlation between glycoprotein quantity and age was positive, but feeble. This investigation is first in Bulgaria to demonstrate significantly elevated serum YKL-40 level in breast carcinoma compared to women with benign breast tumors and healthy controls. Longitudinal studies are needed to confirm YKL-40 as a potential and reliable biomarker.

Authors and Affiliations

Maria Kazakova, Tanya Deneva, Vanya Uzunova, Victoria Sarafian

Keywords

Related Articles

MEDICAL DATA PROTECTION IN RELATION TO HUMAN GENETIC DISCRIMINATION

Information about a person's genetic status can lead to discrimination by excluding the person from particular jobs (for which a particular genetic trait might indicate a risk) or from health insurance (because of forese...

THERAPEUTIC DIFFICULTIES IN ACHIEVEMENT OF OPTIMAL ROOT COVERAGE AND AESTHETIC IN CLASS III GINGIVAL RECESSION.

The width of the attached gingiva is defined as a distance between the depth of the gingival sulcus or gingival/periodontal pocket to the mucogingival junction. Authors suggest that a minimal amount of attached gingiva i...

 BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA

 Objective: Bevacizumab improved survival when added to chemotherapy for patients with metastatic colorectal cancer (mCRC). The aim of this study was to explore the efficacy and safety of Bevacizumab containing chem...

FEMORAL NECK FRACTURES – BIOLOGICAL ASPECTS AND RISK FACTORS.

The strength of the bone is a function of its mechanical properties and bone geometry. The probability of the occurrence of femoral neck fracture is associated with both the trauma mechanism and magnitude of the acting f...

ASPECTS OF CYCLON AND BDNF GENE EXPRESSION IN SCHIZOPHRENIA PATIENTS

The pathogenesis of the schizophrenic illness is still not fully elucidated. Many studies have been conducted revealing different aspects but may be the studies of greatest significance are studying the genetic aspects o...

Download PDF file
  • EP ID EP109945
  • DOI 10.5272/jimab.1632010_3-7
  • Views 100
  • Downloads 0

How To Cite

Maria Kazakova, Tanya Deneva, Vanya Uzunova, Victoria Sarafian (2010). YKL-40 IN SERA OF BREAST TUMOR PATIENTS. Journal of IMAB - Annual Proceeding (Scientific Papers), 16(3), 3-7. https://europub.co.uk/articles/-A-109945